Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron and Urinary Microbiome in UUI
NCT02495389Phase 4Completed
- Sponsor
- Loyola University Chicago
- Start
- Jan 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in Urinary urge incontinence (UUI), sponsored by Loyola University Chicago. Started Jan 2015; status: completed.
02
Drugs
mirabegron
03
Conditions
Urinary urge incontinence (UUI)
Beyond the preview
Go deeper on NCT02495389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495389.